The Advanced Imaging Program (Program 5) is a highly integrated and collaborative program. Given the crucial impact of imaging in cancer diagnosis and treatment, the Program plays a key role in research at the UCCRC. It consists of 24 members from two Departments, with $5,766,868 in peer-reviewed funding, $2,210,919 of which is from NCI. Of 229 peer-reviewed publications during the current project period, 65 (28%) were intraprogrammatic collaborations, and 34 (15%) represented interprogrammatic collaborations. Imaging is used in virtually every cancer patient, in many animal models of cancer, and in a large number of in vitro cancer-related experiments. Thus, imaging research is fundamental to advanced cancer research. The Advanced Imaging Program is focused on enhancing the collaboration among imaging scientists involved in cancer research at the University of Chicago. Recent advances in image analysis methods, as well as in computer processing speeds, have led to, and facilitated, an expanded interest in research in quantitative image analysis. Image analysis investigations now underway within the UCCRC include work with x-ray, ultrasound, magnetic resonance, and radionuclide images, and molecular and physiological modeling. Imaging system research within the UCCRC continues to expand with the establishment of more animal imaging facilities for both basic imaging developments and for use in cancer research that uses animal models. The overall objective of the UCCRC Advanced Imaging Program is to integrate and focus the work of investigators with established research programs, to investigate new methods for the production and analysis of images for prevention, diagnosis, and treatment of cancer, and to translate developed methods from the laboratory to the clinical arena. The research objectives are to: ? Investigate new methods for computerized image analysis to help in the early diagnosis of cancer; ? Investigate new methods of image reconstruction for use in CT (computed tomography), SPECT (single photon emission computed tomography), and PET imaging; ? Develop new methods of image acquisition such as MRIS (magnetic resonance imaging and spectroscopy) and EPR (electron paramagnetic resonance imaging); ? Identify imaging methods for oncology practice and for the evaluation of response to target-based cancer drugs;and ? Investigate methods for the evaluation of imaging systems, especially as they apply to computeraided diagnosis and new imaging instrumentation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-36
Application #
8244540
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-04-01
Budget End
2012-03-31
Support Year
36
Fiscal Year
2011
Total Cost
$41,592
Indirect Cost
Name
University of Chicago
Department
Type
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637
Hope, C Matthew; Webber, Jemma L; Tokamov, Sherzod A et al. (2018) Tuned polymerization of the transcription factor Yan limits off-DNA sequestration to confer context-specific repression. Elife 7:
Wu, Chengyue; Pineda, Federico; Hormuth 2nd, David A et al. (2018) Quantitative analysis of vascular properties derived from ultrafast DCE-MRI to discriminate malignant and benign breast tumors. Magn Reson Med :
Wong, Gabrielle S; Zhou, Jin; Liu, Jie Bin et al. (2018) Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition. Nat Med 24:968-977
Ni, Kaiyuan; Lan, Guangxu; Chan, Christina et al. (2018) Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy. Nat Commun 9:2351
Meisel, Marlies; Hinterleitner, Reinhard; Pacis, Alain et al. (2018) Microbial signals drive pre-leukaemic myeloproliferation in a Tet2-deficient host. Nature 557:580-584
Webber, Jemma L; Zhang, Jie; Massey, Alex et al. (2018) Collaborative repressive action of the antagonistic ETS transcription factors Pointed and Yan fine-tunes gene expression to confer robustness in Drosophila. Development 145:
Wei, Jiangbo; Liu, Fange; Lu, Zhike et al. (2018) Differential m6A, m6Am, and m1A Demethylation Mediated by FTO in the Cell Nucleus and Cytoplasm. Mol Cell 71:973-985.e5
Boisclair Lachance, Jean-François; Webber, Jemma L; Hong, Lu et al. (2018) Cooperative recruitment of Yan via a high-affinity ETS supersite organizes repression to confer specificity and robustness to cardiac cell fate specification. Genes Dev 32:389-401
Szmulewitz, Russell Z; Peer, Cody J; Ibraheem, Abiola et al. (2018) Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer. J Clin Oncol 36:1389-1395
Maron, Steven B; Alpert, Lindsay; Kwak, Heewon A et al. (2018) Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for EGFR-Amplified Gastroesophageal Adenocarcinoma. Cancer Discov 8:696-713

Showing the most recent 10 out of 668 publications